2.Updates on biologic function of tumor suppressor gene inhibitor of growth family and related studies.
Chinese Journal of Pathology 2009;38(12):859-861
Animals
;
Apoptosis
;
Cell Cycle
;
Cell Cycle Proteins
;
genetics
;
metabolism
;
physiology
;
DNA Repair
;
Homeodomain Proteins
;
genetics
;
metabolism
;
physiology
;
Humans
;
Inhibitor of Growth Protein 1
;
Intracellular Signaling Peptides and Proteins
;
genetics
;
metabolism
;
physiology
;
Neoplasm Metastasis
;
Neoplasms
;
metabolism
;
pathology
;
Neovascularization, Pathologic
;
pathology
;
Nuclear Proteins
;
genetics
;
metabolism
;
physiology
;
Prognosis
;
Receptors, Cytoplasmic and Nuclear
;
genetics
;
metabolism
;
physiology
;
Signal Transduction
;
Transcription Factors
;
genetics
;
metabolism
;
physiology
;
Tumor Suppressor Protein p53
;
metabolism
;
Tumor Suppressor Proteins
;
chemistry
;
genetics
;
metabolism
;
physiology
5.Treatment progress of extranodal NK/T cell lymphoma
Ming-zhi ZHANG ; Zheng-feng ZHU
Journal of Leukemia & Lymphoma 2011;20(10):626-628
Extranodal NK/T cell lymphoma is a kind of disease that is associated with EB virus infection and characterized by progressive distruction and necrosis of the nasal cavity and midline facial tissues, with histological features of diffuse lymphomatous cells inflitrate and inflammatory cells as abackground or angiocentric and angioinvasive inflitrate.The prognosis is poor,as it is highly aggressive and it can progress rapidly.This article mainly discusses and reviews the progress in treatment methods.
7.Tumor suppressor gene ING1 differentially regulates HepG2 cell growth in an isoform-dependent manner.
Zhi ZHU ; Yong-mei LI ; Zhi-gang LUO ; Ying CHEN ; Ming-hua ZHU
Chinese Journal of Pathology 2009;38(9):623-625
Alternative Splicing
;
Apoptosis
;
Cell Cycle
;
Cell Proliferation
;
Cyclin-Dependent Kinase Inhibitor p21
;
metabolism
;
Hep G2 Cells
;
Humans
;
Inhibitor of Growth Protein 1
;
Intracellular Signaling Peptides and Proteins
;
genetics
;
metabolism
;
physiology
;
Nuclear Proteins
;
genetics
;
metabolism
;
physiology
;
Plasmids
;
Protein Isoforms
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Recombinant Proteins
;
genetics
;
metabolism
;
Transfection
;
Tumor Suppressor Protein p53
;
metabolism
;
Tumor Suppressor Proteins
;
genetics
;
metabolism
;
physiology
;
bcl-2-Associated X Protein
;
metabolism
9.Secretory Expression of the Fusion Protein PTH-HSA in Pichia pastoris
Jun WANG ; Wei SHEN ; Zhi-Ming RAO ; Ge-Jian ZHU ;
China Biotechnology 2006;0(02):-
The fused gene (PTH-HSA) of parathyroid hormone (PTH) gene and Human Serum Albumin(HSA) gene was amplified without linker by Overlapping PCR technology. The spliced gene was clone into Pichia pastoris secretory vector pPIC9K. With the help of promoter AOX1 and mat ? signal peptide, the PTH-HSA gene was designed to secretory expression.Linearized by restriction enzyme SalI, The recombinant plasmid pPIC9K/PTH-HSA was transformed into Pichia pastoris KM71 by electroporation. The recombinant strains which were identified by G418 and PCR analysis were induced by methanol to express protein PTH-HSA. The target protein was expressed in fermentation supernatant. Western blot analysis of the fusion protein showed that the expressed fusion protein PTH-HSA had the antigenicity of HSA.adenylate cyclase assay proved that the fused protein exhibited the bioactivity to stimulate cAMP synthesis The specific activity of broth was about 318IU/ml.
10.Usage of renoportal anastomosis in the liver transplantation
Zhi-Jun ZHU ; Ming-Sheng HUAI ; Ya-Min ZHANG ;
Chinese Journal of Organ Transplantation 2003;0(06):-
Objective To evaluate the usage of renoportal anastomosis in the liver transplanta- tion.Method The successful experience about renoportal anastomosis for portal vein reconstruction in liver transplantation was reported,and related literature reviewed.Results Including our case,there have been 13 cases of liver transplantation using renoportal anastomosis for portal vein reconstruction. Among these patients,8 cases were complicated with diffuse portal vein thrombosis,and 10 cases had a splenorenal shunt(spontaneous shunt in 3 and surgical shunt in 7).Complications related to portal vein hypertension occurred in 3 cases(transient ascites in 2 cases and severe digestive bleeding in 1 case)after liver transplantation.There were 3 deaths which were not related to renoportal anastomo- sis.Conclusion Renoportal anastomosis is a safe and feasible technique in liver transplantation for the patients with diffuse portal vein thrombosis or with splenorenal shunt(spontaneous or surgical shunt).